Featured News

A recent study, published by The American Journal of Gastroenterology has uncovered a new potential method for treating celiac disease. The study, titled “Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders” was first published online on April 8th, 2014. It’s authors, doctors and scientists hailing from all over the world, looked at several different aspects of a protein called elafin and its effect on gluten-related disorders like celiac disease.

A study recently published by The Journal of the American Medical Association has found further evidence for a link between celiac disease and irritable bowel syndrome (IBS). The study, first…

Celiac Disease Foundation (CDF) today released a 7 Day Gluten-Free Meal Plan to help individuals diagnosed with celiac disease or other gluten-related disorders and their families ease the transition to a gluten-free diet. The gluten-free meal plan provides a clear and concise 7 day menu of three meals and two snacks per day with easy to make recipes and “Quick-Fix” options for those on-the-go. This free meal plan, developed with CDF Medical Advisory Board member, Alicia Calvo, RD, CDE, can be accessed at celiac.org/mealplan. In honor of Celiac Awareness Month and to showcase the 7 Day Gluten-Free Meal Plan, CDF is encouraging celiac disease and gluten-sensitivity advocates to participate in its Team Gluten-Free Week without Wheat (Barley and Rye) Challenge. Participants will join CDF Board of Directors’ Treasurer Christopher Holland in committing to eating entirely gluten-free for at least 7 days in the month of May to raise funds and promote awareness of celiac disease and other gluten-related disorders.

Celiac Disease Foundation (CDF), the leading national organization improving the quality of life for all people affected by gluten-related disorders, today announced that over 3000 people are expected in Pasadena on June 7 – 8, 2014, for CDF’s 20th Annual National Conference & Gluten-Free EXPO. Patients, family members, caregivers, health care professionals and gluten-free foodies will converge at the Pasadena Convention Center for this educational and gluten-free experience. The June 7th conference focuses on medical information and updates on celiac disease, one of the world’s most prevalent and under diagnosed genetic autoimmune diseases. The June 8th EXPO celebrates food options now available for people with celiac disease, the gluten-sensitive and others who seek benefit of the gluten-free lifestyle. For many of the conference attendees, this is the first time in which they will be surrounded by a community of people living with celiac disease or gluten-sensitivity.

New Planet Beer announced their sponsorship of Celiac Disease Foundation with the Win a Trip for Two to the 2014 CDF National Conference & Gluten-Free EXPO Sweepstakes.  One lucky individual…

Compared with the general population, individuals with celiac disease were almost twice as likely to have CAD, according to a large retrospective study presented here today at the American College of Cardiology (ACC) 2014 Scientific Sessions [1]. Even patients younger than aged 65 years were at higher risk.

Deborah Ceizler, CDF Chief Development Officer, recently attended the Development of Therapies for Celiac Disease Conference hosted by the Celiac Disease Center at Columbia University.  The conference provided a unique…

By Van Waffle | February 24, 2014   Despite a growing awareness of celiac disease, most people still don’t know they have it. When a pediatrician phoned Marilyn Geller with test results…

Dole Packaged Foods announced today that they are now a proud sponsor of Celiac Disease Foundation (CDF), a national nonprofit organization dedicated to driving early diagnosis and treatment of celiac disease through advocacy, education and advancing research to improve the quality of life for all people affected by gluten-related disorders.

The Alcohol and Tobacco Tax and Trade Bureau (TTB) made a new ruling on how alcohol products can be labeled with respect to gluten. The TTB’s revised ruling on the matter, for the most part, is in line with the FDA.